Newsroom | 5255 results

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2026 results after the financial markets close on Thursday, August 6, 2026. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its second quarter 2026 financial and operating results.A live webcast of the call will be available on Tandem Diabet...

LOS ANGELES--(BUSINESS WIRE)--Die AIDS Healthcare Foundation (AHF) begrüßte das Engagement der Mitgliedstaaten auf der hochrangigen Konferenz der Vereinten Nationen zum Thema HIV/AIDS, unterstrich jedoch gleichzeitig, dass Millionen von Menschen, die mit HIV leben, noch immer keinen Zugang zu lebensrettender Behandlung haben und dass schätzungsweise 1,2 Millionen Menschen jedes Jahr an HIV erkranken. Während Regierungen ihr Engagement für die Beseitigung von AIDS als Bedrohung der öffentlichen...

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) s’est félicité de l’engagement des États membres lors de la réunion de haut niveau des Nations unies sur le VIH/sida de 2026, tout en soulignant que des millions de personnes vivant avec le VIH n’ont toujours pas accès à un traitement vital et qu’environ 1,2 million de personnes contractent le VIH chaque année. Alors que les gouvernements réaffirment leur engagement à mettre fin au sida en tant que menace pour la santé publique, AHF...

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens is supporting the more than 56 million patients in the Medicare network that may be eligible for GLP-1 medications through the Medicare GLP-1 Bridge program. Walgreens pharmacists will help eligible Medicare patients navigate the new program at nearly 8,000 stores across the country. To get started, patients should speak with their healthcare provider about whether they may be eligible. The Medicare Bridge program is a new nationwide initiative from t...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the appointment of Jonathan (“Jay”) Mazelsky to the Company’s Board of Directors, effective July 1, 2026. Mr. Mazelsky joins the Board as an independent director. “We are pleased to welcome Jay to Insulet’s Board of Directors,” said President and CEO Ashley McEvoy. “Jay has a strong track record of...

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) welcomed the engagement of Member States at the 2026 United Nations High-Level Meeting on HIV/AIDS, while emphasizing that millions of people living with HIV still do not have access to lifesaving treatment, and an estimated 1.2 million people acquire HIV each year. As governments reaffirm their commitment to ending AIDS as a public health threat, AHF urged that political promises be matched by the resources needed to turn commitmen...

BOSTON--(BUSINESS WIRE)--Anodyne Nanotech Inc., a clinical-stage biotechnology company simplifying chronic care through transdermal delivery, today announced the closing of a $12.6 million Series A financing. The round was led by Velocity Partners VC and co-led by Evercurious VC, with major participation from Relativity Healthcare Partners. Proceeds from the financing will support the advancement of ANN-101, Anodyne's once-weekly GLP-1 patch for obesity, into a Phase I clinical trial, while acc...

INDIANAPOLIS--(BUSINESS WIRE)--Summit of SNF leaders representing more than 350 facilities identifies clear path forward for operators to take control of transitions of care....

MIAMI & HOUSTON--(BUSINESS WIRE)--The Society for Neuro-Oncology (SNO), the world's largest multidisciplinary organization dedicated to advancing research, education, and clinical care for patients with brain and spinal cord tumors, and OpenEvidence, the leading AI-powered clinical decision support platform, today announced a landmark partnership, designating OpenEvidence as SNO's official generative AI partner. As part of the collaboration, SNO will embed OpenEvidence across its member-facing...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced at Aspen Ideas: Health a series of milestones that advance its vision of making glucose biosensing more accessible. Notably, the company announced pediatric clearance for the Stelo Glucose Biosensor and the launch of its fully reimagined Stelo app experience in July for Apple iPhone and Android users in the United States.“Glucose matters for everyone and better understanding it can h...